Özkan, T. Et Al. 2021. Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells. LEUKEMIA RESEARCH , vol.102 .

Özkan, T., Hekmatshoar, Y., Karabay, A. Z., Koç, A., Altınok Güneş, B., Gurel, A. K., ... Sunguroğlu, A.(2021). Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells. LEUKEMIA RESEARCH , vol.102.

Özkan, TÜLİN Et Al. "Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells," LEUKEMIA RESEARCH , vol.102, 2021

Özkan, TÜLİN Et Al. "Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells." LEUKEMIA RESEARCH , vol.102, 2021

Özkan, T. Et Al. (2021) . "Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells." LEUKEMIA RESEARCH , vol.102.

@article{article, author={TÜLİN ÖZKAN Et Al. }, title={Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells}, journal={LEUKEMIA RESEARCH}, year=2021}